TABLE 1.
Population characteristics
| C1 (N = 30) | C2 (N = 56) | |
|---|---|---|
| Median age (years) | 49 | 52 |
| Gender (M/F) | 21/9 | 32/24 |
| Primary site | ||
| Trunk | 1 | 6 |
| Upper limbs/girdles | 3 | 9 |
| Lower limbs/girdles | 26 | 41 |
| Median primary size (mm) | 84 | 99 |
| Histology | ||
| Myxoid‐round cell liposarcoma | 12 | 0 |
| Synovial sarcoma | 9 | 4 |
| Malignant peripheral nerve sheath tumor | 2 | 8 |
| Leiomyosarcoma | 0 | 7 |
| Undifferentiated pleomorphic sarcoma | 4 | 19 |
| Myxofibrosarcoma | 3 | 11 |
| Unclassified spindle cell | 0 | 1 |
| Pleomorphic liposarcoma | 0 | 5 |
| Pleomorphic rabdomiosarcoma | 0 | 1 |
| FNCLCC Grade | ||
| 2 | 6 | 2 |
| 3 | 24 | 54 |
| Regimen | ||
| Standard chemotherapy | 17 | 39 |
| Histology‐tailored chemotherapy | 13 | 17 |
| Radiation therapy (pre‐ or post‐operative) | 20 | 45 |